Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease

Neurocrine Clinical Site, Williamsville

Neurocrine Clinical Site, Rochester

Neurocrine Clinical Site, Pittsburgh

Neurocrine Clinical Site, Washington D.C.

Neurocrine Clinical Site, Durham

Neurocrine Clinical Site, Columbia

Neurocrine Clinical Site, Charleston

Neurocrine Clinical Site, Greenville

Neurocrine Clinical Site, Atlanta

Neurocrine Clinical Site, Gainesville

Neurocrine Clinical Site, Boca Raton

Neurocrine Clinical Site, Birmingham

Neurocrine Clinical Site, Nashville

Neurocrine Clinical Site, Louisville

Neurocrine Clinical Site, Columbus

Neurocrine Clinical Site, Toledo

Neurocrine Clinical Site, Indianapolis

Neurocrine Clinical Site, Ann Arbor

Neurocrine Clinical Site, Iowa City

Neurocrine Clinical Site, Chicago

Neurocrine Clinical Site, Chicago

Neurocrine Clinical Site, Wichita

Neurocrine Clinical Site, Omaha

Neurocrine Clinical Site, New Orleans

Neurocrine Clinical Site, Little Rock

Neurocrine Clinical Site, Houston

Neurocrine Clinical Site, Aurora

Neurocrine Clinical Site, La Jolla

Neurocrine Clinical Site, Boston

Neurocrine Clinical Site, Charlestown

Neurocrine Clinical Site, Burlington

Neurocrine Clinical Site, Vancouver

Neurocrine Clinical Site, Ottawa

Neurocrine Clinical Site, Toronto